Loading patent…
AssigneesNational Taiwan University, Conmed Pharmaceutical & Bio-Medical Corporation
InventorsChen-Yu Fang, Bao-Ji Chen, Ming-Ju Chen, Je-Ruei Liu
Estimating the term…
The invention relates to a probiotic composition for reducing uremic toxins and the manufacturing method thereof. The probiotic composition comprises at least one selected from the group consisting of: Lactobacillus plantarum BCRC 12251, Lactobacillus paracasei BCRC 12188, Streptococcus thermophilus BCRC 13869 and pharmaceutically acceptable vehicles, excipients, diluents, adjuvants, etc. The invention further relates to a probiotic composition consisted of Lactobacillus plantarum BCRC 12251, Lactobacillus paracasei BCRC 12188, Streptococcus thermophilus BCRC 13869 and pharmaceutically acceptable vehicles, excipients, diluents, adjuvants, etc. In addition, the invention relates to a novel use of the probiotic composition for reducing uremic toxins, wherein the uremic toxins are protein-bound uremic toxins.
A method for reducing uremic toxins by using probiotic compositions, wherein the probiotic composition comprises at least one selected from the group consisting of:
A probiotic composition for reducing uremic toxins, and said composition comprises Lactobacillus plantarum BCRC 12251, Lactobacillus paracasei BCRC 12188, Streptococcus thermophilus BCRC 13869 and pharmaceutically acceptable vehicles, excipients, diluents and adjuvants.
Dependencies are inferred from the claim text.